Paul Thambi

Paul Thambi is a co-founder and Chief Medical Officer (CMO) at Sunstone Therapies since July 2020. Prior to that, they worked at Maryland Oncology Hematology for eighteen years, starting in February 2004. At Maryland Oncology Hematology, they held the position of Partner until January 2022.

Paul Thambi's education history is as follows:

From 2018 to 2019, Paul Thambi attended the California Institute of Integral Studies, where they pursued a degree in the Center for Psychedelic Therapies and Research.

Between 2000 and 2004, Paul Thambi studied at the National Cancer Institute, specializing in Oncology and Hematology during their fellowship.

From 1996 to 1999, Paul Thambi completed their Internal Medicine Residency Program at Rush Medical College of Rush University Medical Center.

In 1992, Paul Thambi obtained their Doctor of Medicine (MD) degree from The Ohio State University.

During the years 1986 to 1990, Paul Thambi attended Purdue University, where they earned a Bachelor of Science (BS) degree in Electrical, Electronics, and Communications Engineering.